Found: 150
Select item for more details and to access through your institution.
Clinical Trials in Times of War: A Testament to Human Resilience and Dedication.
- Published in:
- Movement Disorders, 2024, v. 39, n. 10, p. 1896, doi. 10.1002/mds.29920
- By:
- Publication type:
- Article
Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 10, p. 6729, doi. 10.1007/s00415-024-12614-8
- By:
- Publication type:
- Article
Correction: Predictors of low quality of life after open inguinal hernia repair using the EuraHS-QoL score: prospective multicentric cohort study across 33 hospitals.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Should the Energy Contribution of Commercial Thickeners Be Considered in the Nutrition Plan of Patients With Dysphagia?
- Published in:
- Nutrition in Clinical Practice, 2020, v. 35, n. 4, p. 649, doi. 10.1002/ncp.10408
- By:
- Publication type:
- Article
Smartphone-Based Body Location-Independent Functional Mobility Analysis in Patients with Parkinson's Disease: A Step towards Precise Medicine.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 5, p. 826, doi. 10.3390/jpm12050826
- By:
- Publication type:
- Article
Moving towards Integrated and Personalized Care in Parkinson's Disease: A Framework Proposal for Training Parkinson Nurses.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 7, p. 623, doi. 10.3390/jpm11070623
- By:
- Publication type:
- Article
Validation of a Lower Back “Wearable”-Based Sit-to-Stand and Stand-to-Sit Algorithm for Patients With Parkinson's Disease and Older Adults in a Home-Like Environment.
- Published in:
- Frontiers in Neurology, 2018, p. N.PAG, doi. 10.3389/fneur.2018.00652
- By:
- Publication type:
- Article
A Computational Analysis in a Cohort of Parkinson's Disease Patients and Clock-Modified Colorectal Cancer Cells Reveals Common Expression Alterations in Clock-Regulated Genes.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5978, doi. 10.3390/cancers13235978
- By:
- Publication type:
- Article
Neuroimaging cerebrovascular biomarkers in Parkinson's disease.
- Published in:
- Neuroradiology Journal, 2022, v. 35, n. 4, p. 490, doi. 10.1177/19714009211059118
- By:
- Publication type:
- Article
Risk of SARS‐CoV‐2 Infection and COVID‐19 Severity Associated With Exposure to Nonsteroidal Anti‐Inflammatory Drugs: Systematic Review and Meta‐Analysis.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 12, p. 1521, doi. 10.1002/jcph.1949
- By:
- Publication type:
- Article
Limitations of current Parkinson's disease therapy.
- Published in:
- Annals of Neurology, 2003, v. 53, n. s3, p. S3
- By:
- Publication type:
- Article
Reply to: "Rethinking Parkinson's Disease: A Syndromic Perspective".
- Published in:
- Movement Disorders, 2024, v. 39, n. 6, p. 1080, doi. 10.1002/mds.29832
- By:
- Publication type:
- Article
Defining the Riddle in Order to Solve It: There Is More Than One "Parkinson's Disease".
- Published in:
- Movement Disorders, 2023, v. 38, n. 7, p. 1127, doi. 10.1002/mds.29419
- By:
- Publication type:
- Article
The Lessebo Effect in Disease Modification Trials in Parkinson's Disease.
- Published in:
- Movement Disorders, 2023, v. 38, n. 7, p. 1346, doi. 10.1002/mds.29414
- By:
- Publication type:
- Article
Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease.
- Published in:
- Movement Disorders, 2022, v. 37, n. 11, p. 2272, doi. 10.1002/mds.29193
- By:
- Publication type:
- Article
Reply to: An MDS Evidence-Based Review on Treatments for Huntington's Disease.
- Published in:
- 2022
- By:
- Publication type:
- letter
An MDS Evidence‐Based Review on Treatments for Huntington's Disease.
- Published in:
- Movement Disorders, 2022, v. 37, n. 1, p. 25, doi. 10.1002/mds.28855
- By:
- Publication type:
- Article
Tremor and Parkinsonism in Chromosomopathies — A Systematic Review.
- Published in:
- Movement Disorders, 2021, v. 36, n. 9, p. 2017, doi. 10.1002/mds.28663
- By:
- Publication type:
- Article
Expectations of Benefit in a Trial of a Candidate Disease‐Modifying Treatment for Parkinson Disease.
- Published in:
- Movement Disorders, 2021, v. 36, n. 8, p. 1964, doi. 10.1002/mds.28630
- By:
- Publication type:
- Article
Unsupervised Walking Activity Assessment Reveals COVID‐19 Impact on Parkinson's Disease Patients.
- Published in:
- Movement Disorders, 2021, v. 36, n. 3, p. 531, doi. 10.1002/mds.28514
- By:
- Publication type:
- Article
N-Terminal Pro-B-Type Natriuretic Peptide Levels in Parkinson's Disease.
- Published in:
- 2020
- By:
- Publication type:
- letter
A Standardized MR Imaging Protocol for Parkinsonism.
- Published in:
- Movement Disorders, 2020, v. 35, n. 10, p. 1745, doi. 10.1002/mds.28204
- By:
- Publication type:
- Article
The "long and winding road" of the disease-modifying effects of levodopa has not ended yet.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Swimming is compromised in Parkinson's disease patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A critique of the second consensus criteria for multiple system atrophy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
MDS evidence-based review of treatments for essential tremor.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Risk of drowning in people with Parkinson's disease.
- Published in:
- 2018
- By:
- Publication type:
- letter
The placebo response in Parkinson's disease and other movement disorders.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Placebo and nocebo responses in other movement disorders besides Parkinson's disease: How much do we know?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Why Palliative Care Applies to Parkinson's Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Critical appraisal of clinical trials in multiple system atrophy: Toward better quality.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Neuromelanin magnetic resonance imaging of the substantia nigra in LRRK2-related Parkinson's disease.
- Published in:
- 2017
- By:
- Publication type:
- letter
Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Twelve-week sensor assessment in Parkinson's disease: Impact on quality of life.
- Published in:
- 2016
- By:
- Publication type:
- letter
New methods for the assessment of Parkinson's disease (2005 to 2015): A systematic review.
- Published in:
- 2016
- By:
- Publication type:
- journal article
New treatments for levodopa-induced motor complications.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trial.
- Published in:
- Movement Disorders, 2015, v. 30, n. 10, p. 1426, doi. 10.1002/mds.26308
- By:
- Publication type:
- Article
Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease.
- Published in:
- Movement Disorders, 2015, v. 30, n. 7, p. 953, doi. 10.1002/mds.26182
- By:
- Publication type:
- Article
Quantitative wearable sensors for objective assessment of Parkinson's disease.
- Published in:
- Movement Disorders, 2013, v. 28, n. 12, p. 1628, doi. 10.1002/mds.25628
- By:
- Publication type:
- Article
Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism.
- Published in:
- Movement Disorders, 2013, v. 28, n. 9, p. 1212, doi. 10.1002/mds.25556
- By:
- Publication type:
- Article
The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis.
- Published in:
- Clinical Research in Cardiology, 2021, v. 110, n. 2, p. 183, doi. 10.1007/s00392-020-01697-8
- By:
- Publication type:
- Article
Correction to: Immune‑related serious adverse events with immune checkpoint inhibitors: systematic review and network meta‑analysis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 5, p. 677, doi. 10.1007/s00228-024-03647-z
- By:
- Publication type:
- Article
Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 6, p. 945, doi. 10.3390/biom10060945
- By:
- Publication type:
- Article
Clinical Utility of Opicapone in the Management of Parkinson's Disease: A Short Review on Emerging Data and Place in Therapy.
- Published in:
- Degenerative Neurological & Neuromuscular Disease, 2021, v. 11, p. 29, doi. 10.2147/DNND.S256722
- By:
- Publication type:
- Article
Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Kinematic and Clinical Outcomes to Evaluate the Efficacy of a Multidisciplinary Intervention on Functional Mobility in Parkinson's Disease.
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2021.637620
- By:
- Publication type:
- Article
Patients and Health Professional's Perspective of Functional Mobility in Parkinson's Disease.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.575811
- By:
- Publication type:
- Article